Golgi post-translational modifications and associated diseases

Journal of Inherited Metabolic Disease

Volumn 38, Issue 4, 2015, Pages 741-751

  Potelle, Sven ^a   Klein, André ^a   Foulquier, François ^a  

^a UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; ALPHA MANNOSIDASE; ARYLSULFATASE; CALMODULIN; CALMODULIN LYSINE N METHYLTRANSFERASE; CARRIER PROTEINS AND BINDING PROTEINS; CHONDROITIN 6 SULFATE; COAT PROTEIN COMPLEX II; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYTIDINE PHOSPHATE N ACYLNEURAMINATE PHOSPHODIESTERASE; CYTOPLASM PROTEIN; DERMATAN SULFATE; GOLGI RESIDENT PAP PHOSPHATASE; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINE 6 SULFATASE; N ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE ALPHA SUBUNIT; N ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE BETA SUBUNIT; N ACETYLGLUCOSAMINE PHOSPHOTRANSFERASE GAMMA SUBUNIT; PALMITOYL PROTEIN THIOESTERASE; PHOSPHATASE; PHOSPHOTRANSFERASE; SITE 2 PROTEASE; SOLUTE CARRIER FAMILY 33 MEMBER 1; SULFATE ANION TRANSPORTER; SYNAPTOJANIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE; URIDINE DIPHOSPHATE GALACTOSE;

ACHONDROGENESIS TYPE 1A; ACHONDROGENESIS TYPE 1B; ARTHROGRYPOSIS; BRACHYOLMIA TYPE 4; CHONDRODYSPLASIA; CHONDRODYSPLASIA PUNCTATA; CHROMOSOME DELETION; CHROMOSOME DELETION 2P21; CONGENITAL DISORDER OF GLYCOSYLATION; CONGENITAL DYSERYTHROPOIETIC ANEMIA; CONGENITAL SKIN DISEASE; CORNEA DYSTROPHY; DARIER DISEASE; DIASTROPHIC DYSPLASIA; DYSPLASIA; EHLERS DANLOS SYNDROME; GOLGI COMPLEX; HAPPY PUPPET SYNDROME; HUMAN; INBORN ERROR OF METABOLISM; JOINT DISLOCATION; JOUBERT SYNDROME; LONG QT SYNDROME; MACULAR CORNEAL DYSTROPHY TYPE II; MENTAL DEFICIENCY; MORM SYNDROME; MUCOLIPIDOSIS TYPE 2; MUCOLIPIDOSIS TYPE 3; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; OLMSTED SYNDROME; PALMITOYLATION; PEELING SKIN SYNDROME; PROTEIN ACETYLATION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RAINE SYNDROME; REVIEW; SCHIZOPHRENIA; SPASTIC PARAPLEGIA; SPONDYLOEPIPHYSEAL DYSPLASIA; SULFATION; X LINKED MENTAL RETARDATION; ANIMAL; GENETICS; METABOLIC DISORDER; METABOLISM;

ANIMALS; GOLGI APPARATUS; HUMANS; METABOLIC DISEASES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84937251674     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-015-9851-7     Document Type: Review

References (94)

1. Akama TO, Nishida K, Nakayama J et al (2000) Macular corneal dystrophy type I and type II are caused by distinct mutations in a new sulphotransferase gene. Nat Genet 26:237–241. doi:10.1038/79987
2. Aten E, Brasz LC, Bornholdt D et al (2010) Keratosis follicularis spinulosa decalvans is caused by mutations in MBTPS2. Hum Mutat 31:1125–1133. doi:10.1002/humu.21335
3. Braulke T, Bonifacino JS (2009) Sorting of lysosomal proteins. Biochim Biophys Acta 1793:605–614. doi:10.1016/j.bbamcr.2008.10.016
4. Carchon HA, Ndosimao CN, Aerschot SV, Jaeken J (2006) Use of serum on guthrie cards in screening for congenital disorders of glycosylation. Clin Chem 52:774–775. doi:10.1373/clinchem.2005.063305
5. Cathey SS, Leroy JG, Wood T et al (2010) Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands. J Med Genet 47:38–48. doi:10.1136/jmg.2009.067736
6. Chamberlain SJ, Lalande M (2010) Angelman syndrome, a genomic imprinting disorder of the brain. J Neurosci Off J Soc Neurosci 30:9958–9963. doi:10.1523/JNEUROSCI.1728-10.2010
7. Condon KH, Ho J, Robinson CG et al (2013) The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation. J Neurosci Off J Soc Neurosci 33:3799–3814. doi:10.1523/JNEUROSCI.1930-11.2013
8. Coutinho MF, Prata MJ, Alves S (2012) Mannose-6-phosphate pathway: a review on its role in lysosomal function and dysfunction. Mol Genet Metab 105:542–550. doi:10.1016/j.ymgme.2011.12.012
9. Cylwik B, Lipartowska K, Chrostek L, Gruszewska E (2013a) Congenital disorders of glycosylation. Part II. Defects of protein O-glycosylation. Acta Biochim Pol 60:361–368
10. Cylwik B, Naklicki M, Chrostek L, Gruszewska E (2013b) Congenital disorders of glycosylation. Part I. Defects of protein N-glycosylation. Acta Biochim Pol 60:151–161
11. Denecke J, Kranz C, Nimtz M et al (2008) Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Glycoconj J 25:375–382. doi:10.1007/s10719-007-9089-1
12. Ding YG, Wang JY, Qiao JJ et al (2010) A novel mutation in MBTPS2 causes ichthyosis follicularis, alopecia and photophobia (IFAP) syndrome in a Chinese family. Br J Dermatol 163:886–889. doi:10.1111/j.1365-2133.2010.09890.x
13. Drin G, Morello V, Casella J-F et al (2008) Asymmetric tethering of flat and curved lipid membranes by a golgin. Science 320:670–673. doi:10.1126/science.1155821
14. Dunphy WG, Rothman JE (1985) Compartmental organization of the Golgi stack. Cell 42:13–21
15. Edvardson S, Ashikov A, Jalas C et al (2013) Mutations in SLC35A3 cause autism spectrum disorder, epilepsy and arthrogryposis. J Med Genet 50:733–739. doi:10.1136/jmedgenet-2013-101753
16. Farquhar MG (1985) Progress in unraveling pathways of Golgi traffic. Annu Rev Cell Biol 1:447–488. doi:10.1146/annurev.cb.01.110185.002311
17. Foulquier F (2009) COG defects, birth and rise! Biochim Biophys Acta 1792:896–902. doi:10.1016/j.bbadis.2008.10.020
18. Foulquier F, Vasile E, Schollen E et al (2006) Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. Proc Natl Acad Sci U S A 103:3764–3769. doi:10.1073/pnas.0507685103
19. Foulquier F, Ungar D, Reynders E et al (2007) A new inborn error of glycosylation due to a Cog8 deficiency reveals a critical role for the Cog1-Cog8 interaction in COG complex formation. Hum Mol Genet 16:717–730. doi:10.1093/hmg/ddl476
20. Freeze HH (2013) Understanding human glycosylation disorders: biochemistry leads the charge. J Biol Chem 288:6936–6945. doi:10.1074/jbc.R112.429274
21. Freeze HH, Chong JX, Bamshad MJ, Ng BG (2014) Solving glycosylation disorders: fundamental approaches reveal complicated pathways. Am J Hum Genet 94:161–175. doi:10.1016/j.ajhg.2013.10.024
22. Glick BS, Luini A (2011) Models for Golgi traffic: a critical assessment. Cold Spring Harb Perspect Biol 3:a005215. doi:10.1101/cshperspect.a005215
23. Hackler R, Arndt T, Helwig-Rolig A et al (2000) Investigation by isoelectric focusing of the initial carbohydrate-deficient transferrin (CDT) and non-CDT transferrin isoform fractionation step involved in determination of CDT by the ChronAlcoI.D. assay. Clin Chem 46:483–492
24. Haghighi A, Scott CA, Poon DS et al (2013) A missense mutation in the MBTPS2 gene underlies the X-linked form of Olmsted syndrome. J Investig Dermatol 133:571–573. doi:10.1038/jid.2012.289
25. Hennet T (2012) Diseases of glycosylation beyond classical congenital disorders of glycosylation. Biochim Biophys Acta 1820:1306–1317. doi:10.1016/j.bbagen.2012.02.001
26. Hirabayashi Y, Nomura KH, Nomura K (2013) The acetyl-CoA transporter family SLC33. Mol Aspects Med 34:586–589. doi:10.1016/j.mam.2012.05.009
27. Honke K, Taniguchi N (2002) Sulfotransferases and sulfated oligosaccharides. Med Res Rev 22:637–654. doi:10.1002/med.10020
28. Jaeken J (2011) Congenital disorders of glycosylation (CDG): it’s (nearly) all in it! J Inherit Metab Dis 34:853–858. doi:10.1007/s10545-011-9299-3
29. Jaeken J, Matthijs G (2001) Congenital disorders of glycosylation. Annu Rev Genomics Hum Genet 2:129–151. doi:10.1146/annurev.genom.2.1.129
30. Jonas MC, Pehar M, Puglielli L (2010) AT-1 is the ER membrane acetyl-CoA transporter and is essential for cell viability. J Cell Sci 123:3378–3388. doi:10.1242/jcs.068841
31. Kamiyama S, Suda T, Ueda R et al (2003) Molecular cloning and identification of 3’-phosphoadenosine 5’-phosphosulfate transporter. J Biol Chem 278:25958–25963. doi:10.1074/jbc.M302439200
32. Kamiyama S, Sasaki N, Goda E et al (2006) Molecular cloning and characterization of a novel 3’-phosphoadenosine 5’-phosphosulfate transporter, PAPST2. J Biol Chem 281:10945–10953. doi:10.1074/jbc.M508991200
33. Kang C, Drayna D (2011) Genetics of speech and language disorders. Annu Rev Genomics Hum Genet 12:145–164. doi:10.1146/annurev-genom-090810-183119
34. Kehoe JW, Bertozzi CR (2000) Tyrosine sulfation: a modulator of extracellular protein-protein interactions. Chem Biol 7:R57–R61
35. Klein A, Roussel P (1998) O-Acetylation of sialic acids. Biochimie 80:49–57. doi:10.1016/S0300-9084(98)80056-4
36. Kodera H, Nakamura K, Osaka H et al (2013) De novo mutations in SLC35A2 encoding a UDP-galactose transporter cause early-onset epileptic encephalopathy. Hum Mutat 34:1708–1714. doi:10.1002/humu.22446
37. Kodera H, Ando N, Yuasa I et al (2014) Mutations in COG2 encoding a subunit of the conserved oligomeric golgi complex cause a congenital disorder of glycosylation. Clin Genet. doi:10.1111/cge.12417
38. Koike T, Izumikawa T, Tamura J-I, Kitagawa H (2009) FAM20B is a kinase that phosphorylates xylose in the glycosaminoglycan-protein linkage region. Biochem J 421:157–162. doi:10.1042/BJ20090474
39. Kranz C, Ng BG, Sun L et al (2007) COG8 deficiency causes new congenital disorder of glycosylation type IIh. Hum Mol Genet 16:731–741. doi:10.1093/hmg/ddm028
40. Krasnewich D (2014) Human glycosylation disorders. Cancer Biomarkers Sect Dis Markers 14:3–16. doi:10.3233/CBM-130374
41. Lin P, Li J, Liu Q et al (2008) A missense mutation in SLC33A1, which encodes the acetyl-CoA transporter, causes autosomal-dominant spastic paraplegia (SPG42). Am J Hum Genet 83:752–759. doi:10.1016/j.ajhg.2008.11.003
42. Liu H, Abecasis GR, Heath SC et al (2002) Genetic variation in the 22q11 locus and susceptibility to schizophrenia. Proc Natl Acad Sci U S A 99:16859–16864. doi:10.1073/pnas.232186099
43. Lübbehusen J, Thiel C, Rind N et al (2010) Fatal outcome due to deficiency of subunit 6 of the conserved oligomeric Golgi complex leading to a new type of congenital disorders of glycosylation. Hum Mol Genet 19:3623–3633. doi:10.1093/hmg/ddq278
44. Magen S, Magnani R, Haziza S et al (2012) Human calmodulin methyltransferase: expression, activity on calmodulin, and Hsp90 dependence. PLoS One 7, e52425. doi:10.1371/journal.pone.0052425
45. Magnani R, Dirk LMA, Trievel RC, Houtz RL (2010) Calmodulin methyltransferase is an evolutionarily conserved enzyme that trimethylates Lys-115 in calmodulin. Nat Commun 1:43. doi:10.1038/ncomms1044
46. Mandal C, Mandal C, Chandra S et al (2012) Regulation of O-acetylation of sialic acids by sialate-O-acetyltransferase and sialate-O-acetylesterase activities in childhood acute lymphoblastic leukemia. Glycobiology 22:70–83. doi:10.1093/glycob/cwr106
47. Mansouri MR, Marklund L, Gustavsson P et al (2005) Loss of ZDHHC15 expression in a woman with a balanced translocation t(X;15)(q13.3;cen) and severe mental retardation. Eur J Hum Genet EJHG 13:970–977. doi:10.1038/sj.ejhg.5201445
48. Mao F, Li Z, Zhao B et al (2015) Identification and Functional Analysis of a SLC33A1: c.339 T > G (p.Ser113Arg) Variant in the Original SPG42 Family. Hum Mutat 36:240–249. doi:10.1002/humu.22732
49. Miller VJ, Ungar D (2012) Re’COG’nition at the Golgi. Traffic Cph Den 13:891–897. doi:10.1111/j.1600-0854.2012.01338.x
50. Mohamed M, Ashikov A, Guillard M et al (2013) Intellectual disability and bleeding diathesis due to deficient CMP–sialic acid transport. Neurology 81:681–687. doi:10.1212/WNL.0b013e3182a08f53
51. Mollenhauer HH, Morré DJ (1974) Polyribosomes associated with the Golgi apparatus. Protoplasma 79:333–336
52. Nakazawa K, Hassell JR, Hascall VC et al (1984) Defective processing of keratan sulfate in macular corneal dystrophy. J Biol Chem 259:13751–13757
53. Nalbant D, Youn H, Nalbant SI et al (2005) FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics 6:11. doi:10.1186/1471-2164-6-11
54. Neufeld EF (1974) The biochemical basis for mucopolysaccharidoses and mucolipidoses. Prog Med Genet 10:81–101
55. Ng BG, Kranz C, Hagebeuk EEO et al (2007) Molecular and clinical characterization of a Moroccan Cog7 deficient patient. Mol Genet Metab 91:201–204. doi:10.1016/j.ymgme.2007.02.011
56. Ng BG, Buckingham KJ, Raymond K et al (2013) Mosaicism of the UDP-galactose transporter SLC35A2 causes a congenital disorder of glycosylation. Am J Hum Genet 92:632–636. doi:10.1016/j.ajhg.2013.03.012
57. Oeffner F, Fischer G, Happle R et al (2009) IFAP syndrome is caused by deficiency in MBTPS2, an intramembrane zinc metalloprotease essential for cholesterol homeostasis and ER stress response. Am J Hum Genet 84:459–467. doi:10.1016/j.ajhg.2009.03.014
58. Paesold-Burda P, Maag C, Troxler H et al (2009) Deficiency in COG5 causes a moderate form of congenital disorders of glycosylation. Hum Mol Genet 18:4350–4356. doi:10.1093/hmg/ddp389
59. Parvari R, Gonen Y, Alshafee I et al (2005) The 2p21 deletion syndrome: characterization of the transcription content. Genomics 86:195–211. doi:10.1016/j.ygeno.2005.04.001
60. Planey SL, Zacharias DA (2009) Palmitoyl acyltransferases, their substrates, and novel assays to connect them (Review). Mol Membr Biol 26:14–31. doi:10.1080/09687680802646703
61. Rawson RB (2013) The site-2 protease. Biochim Biophys Acta 1828:2801–2807. doi:10.1016/j.bbamem.2013.03.031
62. Rawson RB, Zelenski NG, Nijhawan D et al (1997) Complementation cloning of S2P, a gene encoding a putative metalloprotease required for intramembrane cleavage of SREBPs. Mol Cell 1:47–57
63. Raymond FL, Tarpey PS, Edkins S et al (2007) Mutations in ZDHHC9, which encodes a palmitoyltransferase of NRAS and HRAS, cause X-linked mental retardation associated with a Marfanoid habitus. Am J Hum Genet 80:982–987. doi:10.1086/513609
64. Reynders E, Foulquier F, Leão Teles E et al (2009) Golgi function and dysfunction in the first COG4-deficient CDG type II patient. Hum Mol Genet 18:3244–3256. doi:10.1093/hmg/ddp262
65. Reynders E, Foulquier F, Annaert W, Matthijs G (2011) How Golgi glycosylation meets and needs trafficking: the case of the COG complex. Glycobiology 21:853–863. doi:10.1093/glycob/cwq179
66. Riemersma M, Sandrock J, Boltje TJ et al (2014) Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid. Hum Mol Genet. doi:10.1093/hmg/ddu742
67. Rosnoblet C, Peanne R, Legrand D, Foulquier F (2013) Glycosylation disorders of membrane trafficking. Glycoconj J 30:23–31. doi:10.1007/s10719-012-9389-y
68. Roth J (2002) Protein N-glycosylation along the secretory pathway: relationship to organelle topography and function, protein quality control, and cell interactions. Chem Rev 102:285–303
69. Roth J, Zuber C, Park S et al (2010) Protein N-glycosylation, protein folding, and protein quality control. Mol Cell 30:497–506. doi:10.1007/s10059-010-0159-z
70. Rymen D, Peanne R, Millón MB et al (2013) MAN1B1 deficiency: an unexpected CDG-II. PLoS Genet 9, e1003989. doi:10.1371/journal.pgen.1003989
71. Salaun C, Greaves J, Chamberlain LH (2010) The intracellular dynamic of protein palmitoylation. J Cell Biol 191:1229–1238. doi:10.1083/jcb.201008160
72. Schauer R (2004) Sialic acids: fascinating sugars in higher animals and man. Zool Jena Ger 107:49–64. doi:10.1016/j.zool.2003.10.002
73. Schwarz K, Iolascon A, Verissimo F et al (2009) Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II. Nat Genet 41:936–940. doi:10.1038/ng.405
74. Scott K, Gadomski T, Kozicz T, Morava E (2014) Congenital disorders of glycosylation: new defects and still counting. J Inherit Metab Dis 37:609–617. doi:10.1007/s10545-014-9720-9
75. Seidah NG, Mowla SJ, Hamelin J et al (1999) Mammalian subtilisin/kexin isozyme SKI-1: a widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. Proc Natl Acad Sci U S A 96:1321–1326
76. Smits P, Bolton AD, Funari V et al (2010) Lethal skeletal dysplasia in mice and humans lacking the golgin GMAP-210. N Engl J Med 362:206–216. doi:10.1056/NEJMoa0900158
77. Stanley P (2011) Golgi glycosylation. Cold Spring Harb Perspect Biol. doi:10.1101/cshperspect.a005199
78. Tagliabracci VS, Engel JL, Wen J et al (2012) Secreted kinase phosphorylates extracellular proteins that regulate biomineralization. Science 336:1150–1153. doi:10.1126/science.1217817
79. Tang L, Liang J, Wang W et al (2011) A novel mutation in MBTPS2 causes a broad phenotypic spectrum of ichthyosis follicularis, atrichia, and photophobia syndrome in a large Chinese family. J Am Acad Dermatol 64:716–722. doi:10.1016/j.jaad.2010.02.045
80. Tiede S, Storch S, Lübke T et al (2005) Mucolipidosis II is caused by mutations in GNPTA encoding the alpha/beta GlcNAc-1-phosphotransferase. Nat Med 11:1109–1112. doi:10.1038/nm1305
81. Van Damme P, Hole K, Pimenta-Marques A et al (2011) NatF contributes to an evolutionary shift in protein N-terminal acetylation and is important for normal chromosome segregation. PLoS Genet 7, e1002169. doi:10.1371/journal.pgen.1002169
82. Van Scherpenzeel M, Timal S, Rymen D et al (2014) Diagnostic serum glycosylation profile in patients with intellectual disability as a result of MAN1B1 deficiency. Brain J Neurol 137:1030–1038. doi:10.1093/brain/awu019
83. Varki A, Diaz S (1985) The transport and utilization of acetyl coenzyme A by rat liver Golgi vesicles. J Biol Chem 260:6600–6608
84. Vesa J, Hellsten E, Verkruyse LA et al (1995) Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376:584–587. doi:10.1038/376584a0
85. Vey M, Schäfer W, Berghöfer S et al (1994) Maturation of the trans-Golgi network protease furin: compartmentalization of propeptide removal, substrate cleavage, and COOH-terminal truncation. J Cell Biol 127:1829–1842
86. Wise RJ, Barr PJ, Wong PA et al (1990) Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc Natl Acad Sci U S A 87:9378–9382
87. Wu CC, MacCoss MJ, Mardones G et al (2004a) Organellar proteomics reveals Golgi arginine dimethylation. Mol Biol Cell 15:2907–2919. doi:10.1091/mbc.E04-02-0101
88. Wu X, Steet RA, Bohorov O et al (2004b) Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med 10:518–523. doi:10.1038/nm1041
89. Yaghoobi R, Omidian M, Sina N et al (2007) Olmsted syndrome in an Iranian family: report of two new cases. Arch Iran Med 10:246–249
90. Yang X, Yu W, Shi L et al (2011) HAT4, a Golgi apparatus-anchored B-type histone acetyltransferase, acetylates free histone H4 and facilitates chromatin assembly. Mol Cell 44:39–50. doi:10.1016/j.molcel.2011.07.032
91. Yang Y-S, Wang C-C, Chen B-H et al (2015) Tyrosine sulfation as a protein post-translational modification. Mol Basel Switz 20:2138–2164. doi:10.3390/molecules20022138
92. Young FB, Butland SL, Sanders SS et al (2012) Putting proteins in their place: palmitoylation in Huntington disease and other neuropsychiatric diseases. Prog Neurobiol 97:220–238. doi:10.1016/j.pneurobio.2011.11.002
93. Yu I-M, Hughson FM (2010) Tethering factors as organizers of intracellular vesicular traffic. Annu Rev Cell Dev Biol 26:137–156. doi:10.1146/annurev.cellbio.042308.113327
94. Zhou Z, Sun X, Zou Z et al (2010) PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130. Cell Res 20:1023–1033. doi:10.1038/cr.2010.56